Researchers from the University of California, San Francisco have uncovered a gene-editing technique which could provide safer treatments for patients with cancer and autoimmune diseases. The breakthrough -- which involves the CRISPR/Cas9 system -- w...
Scientists reprogram T Cells to target autoimmune diseases
Researchers from the University of California, San Francisco have uncovered a gene-editing technique which could provide safer treatments for patients with cancer and autoimmune diseases. The breakthrough -- which involves the CRISPR/Cas9 system -- w...
Researchers from the University of San Francisco have uncovered a gene-editing technique which could provide safer treatments for patients with cancer and autoimmune diseases. The breakthrough -- which involves the CRISPR/Cas9 system -- will allow T...
In mid-2016, A federal panel had greenlit the University of Pennsylvania to pursue the first trials using CRISPR gene-editing in the US. It seems the institution has quietly gotten the ball rolling and could theoretically start the study at any time:...
Last month, the FDA approved a gene therapy called Luxturna, which can treat a rare eye disease that causes blindness. Now the treatment has a price tag, CNBC reports. It will cost $425,000 per eye, and while $850,000 is steep, it's lower than the $1...
Initial results from a new gene therapy technique suggest it could open the doors to a cure for "bubble baby" disease. Lacking the ability to ward off even the most common infections, infants born with the genetic disorder -- known as severe combined...
A young boy with a rare genetic skin disorder is alive and well two years after an experimental gene therapy technique was used to grow and replace nine square feet of his skin. The paper, just published in the journal Nature, describes how doctors i...
People with advanced lymphoma now have another type of treatment to consider. The Food and Drug Administration has approved Yescarta, a cell-based gene therapy designed to treat large B-cell lymphoma created by Kite Pharma. It's the second time the F...
The first gene therapy treatment has been approved for use in the United States. The FDA greenlit a procedure that uses a patient's own cells to combat a particular type of leukemia, but will only permit it for children and young adults up to age 25.
When UniQure launched the first commercial gene therapy drug, Glybera, it promised a minor revolution in medicine. By using custom viruses to deliver genes, it could reportedly cure a rare disease (lipoprotein lipase deficiency) with just one round o...